These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9748535)

  • 1. Physiological regulation of eukaryotic topoisomerase II.
    Isaacs RJ; Davies SL; Sandri MI; Redwood C; Wells NJ; Hickson ID
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):121-37. PubMed ID: 9748535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II.
    Lee JH; Berger JM
    Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31671531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of DNA topoisomerase II during the cell cycle.
    Larsen AK; Skladanowski A; Bojanowski K
    Prog Cell Cycle Res; 1996; 2():229-39. PubMed ID: 9552399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic function of DNA topoisomerase II.
    Osheroff N; Zechiedrich EL; Gale KC
    Bioessays; 1991 Jun; 13(6):269-73. PubMed ID: 1654050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
    Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
    Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sp1 mediates cell proliferation-dependent regulation of rat DNA topoisomerase IIalpha gene promoter.
    Yoon JH; Kim JK; Rha GB; Oh M; Park SH; Seong RH; Hong SH; Park SD
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):367-74. PubMed ID: 10567217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.
    Meyer KN; Kjeldsen E; Straub T; Knudsen BR; Hickson ID; Kikuchi A; Kreipe H; Boege F
    J Cell Biol; 1997 Feb; 136(4):775-88. PubMed ID: 9049244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and regulatory characteristics of eukaryotic type II DNA topoisomerase.
    Bakshi RP; Galande S; Muniyappa K
    Crit Rev Biochem Mol Biol; 2001; 36(1):1-37. PubMed ID: 11256504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Age-related changes in the activity and post-translational modification of DNA topoisomerase II in the quail oviduct].
    Schröder HC; Steffen R; Ugarković D; Zahn RK; Müller WE
    Z Gerontol; 1990; 23(3):117-22. PubMed ID: 2168109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.
    Heck MM; Hittelman WN; Earnshaw WC
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1086-90. PubMed ID: 2829215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of DNA topoisomerase II by casein kinase II.
    Alghisi GC; Roberts E; Cardenas ME; Gasser SM
    Cell Mol Biol Res; 1994; 40(5-6):563-71. PubMed ID: 7735331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II.
    Burden DA; Goldsmith LJ; Sullivan DM
    Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):297-304. PubMed ID: 8392338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle-dependent regulation of the mouse DNA topoisomerase IIalpha gene promoter.
    Adachi N; Kobayashi M; Koyama H
    Biochem Biophys Res Commun; 1997 Jan; 230(1):105-9. PubMed ID: 9020022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA topoisomerase II: a review of its involvement in chromosome structure, DNA replication, transcription and mitosis.
    Anderson HJ; Roberge M
    Cell Biol Int Rep; 1992 Aug; 16(8):717-24. PubMed ID: 1332830
    [No Abstract]   [Full Text] [Related]  

  • 15. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
    Williams AO; Isaacs RJ; Stowell KM
    BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme.
    Burden DA; Osheroff N
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):139-54. PubMed ID: 9748545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells.
    Roberge M; Th'ng J; Hamaguchi J; Bradbury EM
    J Cell Biol; 1990 Nov; 111(5 Pt 1):1753-62. PubMed ID: 2172257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3',5'-monophosphate response element-binding protein and related transcription factors.
    Kroll DJ; Sullivan DM; Gutierrez-Hartmann A; Hoeffler JP
    Mol Endocrinol; 1993 Mar; 7(3):305-18. PubMed ID: 8387155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of expression and function of topoisomerase I and II during meiosis in male mice.
    Cobb J; Reddy RK; Park C; Handel MA
    Mol Reprod Dev; 1997 Apr; 46(4):489-98. PubMed ID: 9094096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.